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Abstract The goal of embryo selection models is to select embryos with the highest reproductive potential, whilst minimizing the
rejection of viable embryos. Ultimately, any embryo selection model must be tested on clinical outcome. We therefore retrospec-
tively tested a published blastocyst prediction model on a large combined set of transferred embryos with known clinical outcome.
The model was somewhat effective in that we found a relative increase of 30% for implantation in the model-selected group of embryos.
There was, however, a concomitant large rejection of embryos from our test cohort, which actually resulted in pregnancy. This hy-
pothetical experiment highlights the limitations of predicting blastulation only. Crucially, it illustrates that both sensitivity and speci-
ﬁcity are important parameters when developing embryo selection models for prospective clinical use.
© 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd.
KEYWORDS: assisted reproduction, embryo selection, prediction model, time lapse
Introduction
Time-lapse imaging of human preimplantation embryos has
become rapidly integrated in IVF laboratories. The pro-
posed advantages, such as uninterrupted embryo culture, ﬂex-
ibility in timing, improvement of documentation procedures,
quality control and management and, in particular, the in-
troduction of dynamic markers of embryo quality, have
altogether stimulated a profound interest in time-lapse
technology. While a large number of publications
consolidate that timing of development differs between viable
and nonviable embryos (Herrero and Meseguer, 2013), only
a few publications offer clinically applicable models of embryo
selection (Campbell et al., 2013; Conaghan et al., 2013;
Meseguer et al., 2011). Yet, as recently demonstrated, a pro-
posed multivariate hierarchical selection model was not trans-
ferable from one clinical setting to another without
modiﬁcation (Best et al., 2013). It has been speculated that
a less-complex model, such as the one recently developed and
applied by Conaghan et al. (2013) that categorized embryos
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into groups with either high or low likelihood of forming ‘usable
blastocysts’, could be applicable to other clinics. The model
has, however, not been evaluated with regard to clinical
outcome. To test this hypothesis and correlation between the
published time intervals and clinical outcome, we retrospec-
tively applied the same model to a large set of transferred
embryos from independent clinics.
Retrospective testing of a blastocyst
prediction model
Seven clinics from three different countries participated by
contributing data on clinical outcome following embryo trans-
fer (fetal heart beat) and timing of cellular divisions until
day 3, obtained using time-lapse monitoring (EmbryoScope,
FertiliTech, Denmark). The ﬁrst division was annotated t2,
second division t3 and the third division t4.
A total of 1519 transferred embryos with known outcome
for implantation from cycles with single (n = 517) or double
(n = 501) embryo transfer were included. In order to be able
to relate each embryo’s fate after transfer with its indi-
vidual morphokinetic proﬁle, only cycles with two or no fetal
heart beats were included where double-embryo transfers
were performed. This implies that the presented pregnancy
rates are lower and not directly comparable with treatment
success rates. Patient stimulation, IVF/intracytoplasmic sperm
injection and embryo culture was performed according to stan-
dard procedures at each site. Embryos were graded and se-
lected according to each clinic’s routine methodology and one
or two embryos were selected for transfer. Embryo transfer
was predominantly performed on day 2 or day 3.
In order to test whether time intervals published in
Conaghan et al. (2013) correlated with clinical outcome, we
retrospectively grouped the transferred embryos into usable
and nonusable embryos based on the model’s values for these
time-lapse intervals. The model was found to predict a high
chance of usable blastocyst formation (deﬁned as a blasto-
cyst suitable for either transfer or freezing) if time between
ﬁrst and second cytokinesis (t3 – t2) was 9.33–11.45 h and time
between second and third cytokinesis (t4 – t3) was 0–1.73 h.
Likewise, embryos were predicted to have a low chance of
forming usable blastocysts if t3 – t2 and t4 – t3 were longer
than these time intervals. We calculated the relative differ-
ence in implantation (%) between the usable group and the
entire cohort, odds ratio for implantation in the usable com-
pared with the nonusable group and the percentage of
nonusable embryos that resulted in implantation. Data were
used to generate a receiver operating characteristic curve and
to calculate area under the curve for implantation.
Data for implantation are presented in Table 1. The rela-
tive difference in implantation rate between the entire cohort
and the embryos categorized as usable by the test model was
30.0%. The odds ratio for implantation between usable and
nonusable was 1.60. The sensitivity was 0.50 and the speci-
ﬁcity was 0.65. Furthermore, 50.6% of the embryos that re-
sulted in pregnancy were categorized as nonusable according
to the model. The area under the curve for prediction of im-
plantation was 0.57 (Figure 1).
In other words, applying the test model retrospectively to
transferred embryos from the independent clinics would have
provided an increase of 30.0% in implantation rate for embryos
grouped as usable compared with the entire test cohort.
Notably, out of the embryos that actually implanted, 50.6%
were categorized as having low chance of being usable. This
indicates that relying on such a model would bring a substan-
tial risk of deeming viable embryos nonusable.
The ultimate goal of embryo selection models is to posi-
tively select embryos with the highest reproductive poten-
tial, notably without rejecting viable embryos. The premise
of this hypothetical experiment is that the test model pre-
dicts the formation of usable blastocysts i.e. blastocysts to
be either transferred or frozen. If embryos are selected for
transfer/freezing on day 3 (as suggested by the authors), it
ultimately follows that blastocysts with a low chance of being
usable are to be discarded if the model is applied uncriti-
cally. Principally, embryos from this study population that have
implanted would have been discarded with day-3 transfer and
application of the time-lapse-based selection model.
This hypothetical experiment illustrates the risks of de-
ﬁning too narrow time intervals for optimal division in
order to achieve a high speciﬁcity at the expense of a low
Table 1 Implantation data for embryos categorized as usable





Usable 131 445 22.7
Nonusable 134 809 14.2
Entire cohort 265 1254 17.4
Values are n or %.
Usable: t3 – t2 = 9.33–11.45 h and t4 – t3 = 0–1.73 h. Unusable: t3 – t2
outside 9.33–11.45 h and t4 – t3 outside 0–1.73 h.
Figure 1 Receiver operating characteristic curve for predic-
tion of pregnancy by the parameters t3 – t2 and t4 – t3 from the
test model.
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sensitivity. It thus underlines the importance of carefully con-
sidering that a model must not only provide a substantial in-
crease in implantation but also, equally important, that a low
rejection rate of viable embryos is secured. This very impor-
tant point is demonstrated by applying the time-lapse crite-
ria on an unprecedented large set of transferred embryos with
a known outcome.
From blastocyst to pregnancy and beyond
The test model was developed in order to identify viable
embryos from a cohort, while the study population is consti-
tuted by embryos selected for transfer with clinical outcome
as the endpoint. Thus, both the endpoint and the study popu-
lation differ between the two studies. It would be expected
that a model that predicts blastocyst development would be
different from a model that predicts clinical outcome. In our
opinion, it would, however, be expected that a model that
predicts blastocyst development would positively select more
embryos than a selection model predictive of implantation
and clinical pregnancy, as embryos resulting in pregnancy
would constitute a subgroup of embryos that develop into blas-
tocysts. We do not, however, ﬁnd any explanation, neither
in the different study populations nor in the different end-
points, as to why a large proportion of embryos which were
rendered ‘unusable’ by the model as they fell outside the
model selection criteria resulted in implantation. In our
opinion, the most likely explanation is the narrow time in-
tervals for optimal cellular division.
Ultimately, any embryo selection model must be tested
on clinical outcome, as blastocyst development is a surro-
gate endpoint, preferably in a prospective study. We believe
that the approach of retrospectively testing the criteria on
transferred embryos with known outcome is justiﬁed in this
case, as it aids the design of future prospective studies.
Our study supports an approach where models are devel-
oped with appropriate concern for low rejection of viable
embryos, where clinical outcome is used as an endpoint and
where the model is individually adjusted to speciﬁc settings
and validated prior to implementation.
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